🏥 治験ポータル
← 治験一覧に戻る

虚血性心筋症に対するヒト(同種)iPS細胞由来心筋細胞シートの臨床試験

基本情報

NCT ID
NCT04696328
ステータス
不明
試験のフェーズ
第1相
試験タイプ
介入
目標被験者数
10
治験依頼者名
Osaka University

概要

Targeting patients with severe ischemic cardiomyopathy, the purpose of this study is as follows: to confirm short-term efficacy by observing changes and transitions in cardiac function and clinical symptoms compared with each patient's baseline (before and after comparison) by human iPS cell-derived cardiomyocyte sheet transplantation, and to evaluate the safety and tolerability including the combined use of immunosuppressants.

対象疾患

Myocardial Ischemia

介入

Human (allogeneic) iPS cell derived-cardiomyocyte sheet(BIOLOGICAL)

依頼者(Sponsor)

Cuorips(UNKNOWN)

実施施設 (1)

大阪大学医学部附属病院

Suita, Osaka, Japan(RECRUITING)